Want to see GB:CRW full AI Analyst Report?
Craneware (CRW) AI Stock Analysis
Craneware
(LSE:CRW)
The score is supported primarily by solid underlying financial quality (low leverage, solid profitability, and strong latest free-cash-flow conversion) and a moderately supportive dividend. It is held back by weak technical momentum (price below all major moving averages with negative MACD) and mixed forward outlook from the earnings call, including a fiscal 2027 revenue reset and uncertainty tied to 340B disruption and cyberattack-related costs.
Craneware (CRW) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 358.81M
- Dividend Yield
- 3.20%
- Average Volume (3M)
- 248.03K
- Price to Earnings (P/E)
- 25.1
- Beta (1Y)
- 0.85
- Revenue Growth
- -3.45%
- EPS Growth
- -1.68%
- Country
- UK
- Employees
- 765
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Craneware Business Overview & Revenue Model
Company Description
Craneware plc, with its associated entities, is dedicated to creating, distributing, and maintaining cutting-edge software applications tailored for the U.S. healthcare industry. Its extensive suite of products is designed to streamline and improve a...
How the Company Makes Money
Craneware makes money primarily by licensing and providing access to its healthcare software solutions and by delivering associated services that support implementation, optimization, and ongoing customer use. Key revenue streams typically include: -...
Craneware Earnings Call Summary
The call had a mixed but cautiously constructive tone. Management emphasized strong ARR, customer retention, cash generation, liquidity, long-term customer relationships, continued product investment, and customer support following the cyber incident. However, these positives were offset by revenue growth falling below expectations, the fiscal 2027 revenue reset to approximately $185 million, 340B-related transactional revenue pressure, lower gross margin, cybersecurity-related data exposure and unknown costs, and continued regulatory uncertainty. Management expects a return to growth and 30% plus margins in fiscal 2028, but fiscal 2027 is positioned as a transition year.
Q4-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For fiscal year ’27, Craneware reset revenue expectations to approximately the level of current ARR, with $185 million as the starting ARR and expected fiscal year ’27 ARR of $185 million; the company is still modeling approximately 100% NRR and is not expecting a drop in ARR. The cost review will be ongoing through the course of this year, with margins not expected to return to 30% plus by the end of this calendar year, but tracking somewhere in the mid- to high 20% margins, while the exit run rate by the end of fiscal ’27 is expected to be aligned to take the company into a 30% plus margin for fiscal ’28. The company expects to return to growth at least into fiscal ’28 and to return to far more positive margins by fiscal ’28, while the cost of the cyberattack remains too hard to quantify and its full impact may take a number of periods, so may extend into future financial years.
Craneware Financial Statement Overview
Summary
Overall financials appear healthy with solid profitability, strong equity backing, and low leverage (debt ~0.15x equity). Free cash flow conversion is strong in the latest year (FCF ~0.99x net income), but revenue softened in the most recent year and both gross margin and operating cash flow have shown notable volatility, reducing predictability.
Income Statement
72PositiveBalance Sheet
80PositiveCash Flow
70Positive| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 204.49M | 206.47M | 205.66M | 189.27M | 174.02M | 165.54M |
| Gross Profit | 137.46M | 138.75M | 179.27M | 162.20M | 148.44M | 142.37M |
| EBITDA | 61.66M | 62.26M | 58.61M | 54.26M | 51.60M | 47.54M |
| Net Income | 19.59M | 19.78M | 19.66M | 11.70M | 9.23M | 9.41M |
Balance Sheet | ||||||
| Total Assets | 524.46M | 524.46M | 551.06M | 543.65M | 576.98M | 568.79M |
| Cash, Cash Equivalents and Short-Term Investments | 55.10M | 55.10M | 55.92M | 34.59M | 78.54M | 47.16M |
| Total Debt | 46.77M | 46.77M | 31.65M | 40.15M | 86.69M | 115.52M |
| Total Liabilities | 204.14M | 204.14M | 213.50M | 215.06M | 249.13M | 235.77M |
| Stockholders Equity | 320.31M | 320.31M | 337.56M | 328.59M | 327.84M | 333.02M |
Cash Flow | ||||||
| Free Cash Flow | 41.47M | 42.26M | 59.41M | 24.91M | 83.20M | 12.93M |
| Operating Cash Flow | 41.94M | 42.74M | 59.90M | 41.86M | 98.75M | 26.96M |
| Investing Cash Flow | -17.19M | -17.40M | -13.98M | -15.81M | -15.34M | -307.32M |
| Financing Cash Flow | -26.13M | -26.44M | -24.58M | -70.00M | -53.28M | 91.90M |
Craneware Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CRW, the sentiment is Negative. The current price of 1048.00 is below the 20-day moving average (MA) of 1087.10, below the 50-day MA of 1173.76, and below the 200-day MA of 1356.29, indicating a bearish trend. The MACD of -20.04 indicates Negative momentum. The RSI at 37.34 is Neutral, neither overbought nor oversold. The STOCH value of 15.38 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:CRW.
Craneware Peers Comparison
Overall Rating
GB:KOO72Outperform
GB:IXI64Neutral- GB:CRW62Neutral
GB:DXRX59Neutral
GB:OPT56Neutral
GB:COG44Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| GB:KOO | 72Outperform | GBP 69.14M | 11.52 | 17.74% | ― | -6.51% | 108.62% |
| GB:IXI | 64Neutral | GBP 25.73M | -5.99 | -16.18% | ― | 13.04% | 15.88% |
| GB:CRW | 62Neutral | GBP 356.58M | 25.07 | 5.94% | 3.20% | -3.45% | -1.68% |
| GB:DXRX | 59Neutral | GBP 172.63M | -635.94 | -0.68% | ― | 20.14% | 82.22% |
| GB:OPT | 56Neutral | GBP 269.22M | 156.65 | 0.83% | ― | 14.84% | -15.14% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| GB:COG | 44Neutral | GBP 15.11M | -9.30 | -54.17% | ― | 11.86% | 23.81% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:CRW | Craneware Plc | 1048.00 | -1159.15 | -52.52% | |
| GB:COG | Cambridge Cognition Holdings | 28.00 | -5.00 | -15.15% | |
| GB:IXI | IXICO plc | 11.75 | 0.25 | 2.17% | |
| GB:KOO | Kooth Plc | 190.00 | 58.00 | 43.94% | |
| GB:DXRX | Diaceutics Plc | 203.50 | 41.00 | 25.23% | |
| GB:OPT | Optima Health PLC | 247.50 | 46.03 | 22.85% |
Craneware Corporate Events
Craneware Audit Chair Susan Nelson Buys Shares, Aligning Further With Investors
PositiveCraneware plc, a specialist in healthcare financial performance and operational transformation, develops cloud‑based analytics and revenue optimization tools for hospitals and health systems. Its Trisus ecosystem integrates data and intelligenc...
Craneware Holds Earnings Steady, Resets Guidance After Cyber Incident and 340B Headwinds
PositiveCraneware reported resilient full-year results for FY26, with revenue broadly flat at $206m, annual recurring revenue steady at $185m and adjusted EBITDA up 3%, supported by high operating cash conversion and strong customer retention. The group main...
Craneware Sets Dates for FY26 Results and Investor Presentations
PositiveCraneware plc, a specialist in healthcare financial performance solutions, is preparing to unveil its audited final results for the year ended 30 June 2026. The company, which offers the Trisus cloud ecosystem to unify data and analytics for hospital...
Craneware Reports Contained Cyber Breach With Limited Operational Impact
NegativeCraneware has disclosed a cyber security incident involving unauthorised access to a subset of its data environment, prompting activation of its incident response plan and the engagement of external cyber security and forensic specialists alongside i...
Craneware CEO Boosts Stake Through Pension Share Purchase
PositiveCraneware plc reported that the pension scheme of chief executive Keith Neilson purchased 9,074 ordinary shares at 1,102 pence each on 6 July 2026. Following this transaction, Neilson’s total holding stands at 3,223,545 shares, representing 9.4...
Craneware Chair Boosts Stake in Healthcare Finance Specialist
PositiveCraneware plc, a specialist in healthcare financial performance and operational transformation solutions, leverages its Trisus cloud ecosystem to unify data, revenue intelligence and margin analytics for healthcare providers. Its technology suite, su...
Craneware Flags FY26 Miss as 340B Slowdown Delays Growth
NegativeCraneware warned that its financial performance for the year to 30 June 2026 will fall short of market expectations, with revenue forecast at US$205–208 million and adjusted EBITDA at US$65–67 million, broadly flat on the prior year. The...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 22, 2026